Vaccine News and Research

Latest Vaccine News and Research

Parainfluenza virus 5 may serve as foundation for next breakthrough in human vaccine development

Researchers at the University of Georgia have discovered that a virus commonly found in dogs may serve as the foundation for the next great breakthrough in human vaccine development.

28 Nov 2012

Microneedle-based measles vaccine can immunize against measles

Measles vaccine given with painless and easy-to-administer microneedle patches can immunize against measles at least as well as vaccine given with conventional hypodermic needles, according to research done by the Georgia Institute of Technology and the Centers for Disease Control and Prevention (CDC).

28 Nov 2012

Scientists adapt modern weather prediction techniques to generate local flu outbreak forecasts

Scientists at Columbia University and the National Center for Atmospheric Research have adapted techniques used in modern weather prediction to generate local forecasts of seasonal influenza outbreaks.

28 Nov 2012

Global Polio Eradication Initiative IMB report optimistic but warns of possible polio resurgence in 2013

Though there is "significant risk" of a resurgence of polio in 2013, a new report from the Independent Monitoring Board (IMB) of the Global Polio Eradication Initiative (GPEI) is optimistic about the eradication of the disease, noting that 99.9 percent of polio has been stopped worldwide, with 175 cases reported so far in 2012 compared with 350,000 reported in 1988, BBC News reports.

28 Nov 2012

Federal travel budget policy affecting global health

Writing in the Diplomatic Courier Blog, Jaclyn Schiff, communications director for the American Society of Tropical Medicine and Hygiene, examines how "an Obama administration effort to curb reckless spending on events" is "making it harder for American researchers to collaborate effectively with their counterparts in other countries."

27 Nov 2012

Liver disease therapies: an interview with Eric Halioua, CEO of Promethera Biosciences

Liver disease is a very broad family of diseases. There are two main categories of liver disease:

27 Nov 2012

New system can predict timing and severity of seasonal influenza outbreaks

Scientists have developed a system to predict the timing and severity of seasonal influenza outbreaks that could one day help health officials and the general public better prepare for them. The system adapts techniques used in modern weather prediction to turn real-time, Web-based estimates of influenza infection into local forecasts of seasonal flu.

27 Nov 2012

Experimental flu vaccine technique could reduce time needed to develop new shots for humans

"An experimental vaccine based on a molecule related to DNA protects animals against influenza and may one day offer an ultra-rapid way to develop new shots for humans, German scientists reported on Sunday," Reuters reports.

27 Nov 2012

Avermectin family of drugs shows promise against TB

A well-established family of drugs used to treat parasitic diseases is showing surprising potential as a therapy for tuberculosis (TB), according to new research from University of British Columbia microbiologists.

26 Nov 2012

Inovio's SynCon DNA vaccine effective at inducing CD8+ T cell responses specific to CMV

Inovio Pharmaceuticals, Inc. announced today that testing of multiple synthetic vaccine constructs for cytomegalovirus (CMV) induced robust T cells in mice, demonstrating the potential for a SynCon DNA vaccine to treat this virus that causes infant death and congenital abnormalities, is associated with cerebral palsy and brain tumors, and is the most common viral infection in organ transplant recipients. CMV is also associated with numerous inflammatory diseases and cancers, and is implicated in hypertension, a major risk factor for cardiovascular diseases.

26 Nov 2012

mRNA vaccines offer protection against influenza A virus infections in various animal models

CureVac GmbH, a clinical stage biopharmaceutical company developing a new class of therapies and vaccines based on mRNA, and the German Federal Research Institute for Animal Health, Friedrich-Loeffler-Institute (FLI), Germany, today announced that mRNA vaccines (RNActive) based on the company's RNA technology platform have the potential to provide effective protection against infectious diseases.

26 Nov 2012

Online flu survey launched in the UK

Does “man flu” exist? How effective is the flu vaccine? And do pets keep you healthy? These are just some of the questions scientists from the London School of Hygiene & Tropical Medicine want to explore as they launch a nationwide flu survey.

22 Nov 2012

Single dose of Medicago's vaccine could offer cross-protection against flu

Researchers recently found that a single dose of a vaccine being developed by Medicago, Inc., a publicly traded biopharmaceutical company, could protect against not only the avian influenza (H5N1) strain it was designed for, but also another H5N1 strain and a strain of a different flu subtype, called H2N2.

22 Nov 2012

Dropping of cold chain requirement for meningitis vaccine will improve access, IRIN reports

IRIN examines how the WHO's recent declaration that the MenAfriVac meningitis A vaccine can be transported or stored for up to four days without refrigeration will affect immunization campaigns in Africa's meningitis belt, which runs from Senegal to Ethiopia.

22 Nov 2012

Genetic study: Novel coronavirus most closely related to viruses in bats

The virus that is causing alarm among global public health authorities after it killed a man in Jeddah, Saudi Arabia earlier this year and is now linked to two other cases of disease is a novel type of coronavirus most closely related to viruses found in bats, according to a genetic analysis to be published in mBio-, the online open-access journal of the American Society for Microbiology, on November 20.

22 Nov 2012

Promising results for pneumococcal vaccine

Research published in The Lancet shows that the PHiD-CV10 vaccine is highly effective at protecting children against invasive pneumococcal disease.

21 Nov 2012

French oil company funding rotavirus research in Congo

"Medical researchers in the Republic of the Congo (Congo-Brazzaville) have been empowered to set their own research priorities through a funding mechanism backed by a French oil company, according to scientists speaking at the second European and Developing Countries Clinical Trials Partnership (EDCTP), in South Africa this month," SciDev.Net reports.

21 Nov 2012

Sudan launches yellow fever vaccination campaign to immunize 2.4M

"Sudan has launched a massive vaccination campaign to immunize 2.4 million people against an outbreak of yellow fever in the restive region of Darfur, the U.N. said Monday," according to the Associated Press.

21 Nov 2012

Novartis receives FDA approval for Flucelvax to prevent seasonal influenza

The U.S. Food and Drug Administration announced today the approval of Flucelvax, the first seasonal influenza vaccine licensed in the United States produced using cultured animal cells, instead of fertilized chicken eggs. Flucelvax is approved to prevent seasonal influenza in people ages 18 years and older.

21 Nov 2012

Emory University, Georgia Tech to establish Malaria Host-Pathogen Interaction Center

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded a five-year contract of up to $19.4 million, depending on contract options exercised, to establish the Malaria Host-Pathogen Interaction Center (MaHPIC).

20 Nov 2012

Vaccine News and Research

Latest Vaccine News and Research

Parainfluenza virus 5 may serve as foundation for next breakthrough in human vaccine development

Microneedle-based measles vaccine can immunize against measles

Scientists adapt modern weather prediction techniques to generate local flu outbreak forecasts

Global Polio Eradication Initiative IMB report optimistic but warns of possible polio resurgence in 2013

Federal travel budget policy affecting global health

Liver disease therapies: an interview with Eric Halioua, CEO of Promethera Biosciences

New system can predict timing and severity of seasonal influenza outbreaks

Experimental flu vaccine technique could reduce time needed to develop new shots for humans

Avermectin family of drugs shows promise against TB

Inovio's SynCon DNA vaccine effective at inducing CD8+ T cell responses specific to CMV

mRNA vaccines offer protection against influenza A virus infections in various animal models

Online flu survey launched in the UK

Single dose of Medicago's vaccine could offer cross-protection against flu

Dropping of cold chain requirement for meningitis vaccine will improve access, IRIN reports

Genetic study: Novel coronavirus most closely related to viruses in bats

Promising results for pneumococcal vaccine

French oil company funding rotavirus research in Congo

Sudan launches yellow fever vaccination campaign to immunize 2.4M

Novartis receives FDA approval for Flucelvax to prevent seasonal influenza

Emory University, Georgia Tech to establish Malaria Host-Pathogen Interaction Center

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in